| Nanomedicines for renal disease: current status and future applications | 2016/10/31 | English | 152 |
| Angiotensin-converting enzyme in innate and adaptive immunity | 2018/03/26 | English | 150 |
| The role of phosphate in kidney disease | 2016/11/21 | English | 150 |
| Pathology of IgA nephropathy | 2014/05/27 | English | 149 |
| Vasopressin: a novel target for the prevention and retardation of kidney disease? | 2013/02/26 | English | 149 |
| Plant-based diets to manage the risks and complications of chronic kidney disease | 2020/06/11 | English | 148 |
| The importance of non-HLA antibodies in transplantation | 2016/06/27 | English | 147 |
| Potential approaches to reverse or repair renal fibrosis | 2014/02/11 | English | 147 |
| MicroRNAs as mediators and therapeutic targets in chronic kidney disease | 2011/03/22 | English | 146 |
| FGF23 at the crossroads of phosphate, iron economy and erythropoiesis | 2019/09/13 | English | 146 |
| The gut–renal axis: do incretin-based agents confer renoprotection in diabetes? | 2013/12/24 | English | 145 |
| Wnt/β-catenin signalling and podocyte dysfunction in proteinuric kidney disease | 2015/06/09 | English | 145 |
| Early chronic kidney disease: diagnosis, management and models of care | 2015/06/09 | English | 144 |
| Mechanisms of cognitive dysfunction in CKD | 2020/03/31 | English | 144 |
| Renal and neurological involvement in typical Shiga toxin-associated HUS | 2012/09/18 | English | 144 |
| Dendritic cells and macrophages in the kidney: a spectrum of good and evil | 2014/09/30 | English | 143 |
| Atherosclerosis in CKD: differences from the general population | 2010/10/26 | English | 143 |
| Role of NAD+ and mitochondrial sirtuins in cardiac and renal diseases | 2017/02/06 | English | 143 |
| CD36 in chronic kidney disease: novel insights and therapeutic opportunities | 2017/09/18 | English | 143 |
| Classification and staging of acute kidney injury: beyond the RIFLE and AKIN criteria | 2011/03/01 | English | 142 |
| The role of Toll-like receptors in renal diseases | 2010/02/23 | English | 139 |
| Lipid management in patients with chronic kidney disease | 2018/10/25 | English | 139 |
| Haemodialysis membranes | 2018/05/05 | English | 138 |
| Pathogenesis of IgA nephropathy | 2012/03/20 | English | 138 |
| Roles of mTOR complexes in the kidney: implications for renal disease and transplantation | 2016/08/01 | English | 137 |
| Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease | 2014/04/01 | English | 136 |
| Pattern recognition receptors and the inflammasome in kidney disease | 2014/06/03 | English | 136 |
| Malignancy after renal transplantation: the role of immunosuppression | 2010/09/01 | English | 135 |
| Plasma cells as an innovative target in autoimmune disease with renal manifestations | 2016/02/29 | English | 135 |
| Understanding the mechanisms of kidney fibrosis | 2015/12/30 | English | 135 |